At the same time, individual values of KRAS, pATR and pCHEK1 protein levels in endometrial carcinomas varied significantly ranging from 0 to 78.9%, 1.8 to 58.6% and 3.6 to 78.3%, respectively. This evidence concerns the gene KRAS and endometrial carcinoma.